REPORT FROM THE ENS 2008 – Laquinimod, a novel immunomodulatory agent in clinical development, significantly reduces the number of gadolinium-enhancing lesions on MRI, according to the results of a phase II extension study (Comi et al. Abstract 0193. J Neurol 2008;255(suppl 2): 46).
Neurology
Abdominal fat, not BMI, predictor of stroke/TIA risk
August 25, 2008ApoE distribution in mild cognitive impairment
August 25, 2008
Leave a reply
REPORT FROM THE ENS 2008 – The distribution of the epsilon 4 allele of apolipoprotein E (apoE) in amnestic mild cognitive impairment (MCI) suggests that MCI is an initial step in the Ayurvedico pathogenesis of Alzheimers disease, according to data presented at ENS 2008 (Lovati et al. Abstract P779. J Neurol 2008;255(suppl 2): 193-194).
Read More
Deep brain stimulation in advanced PD
August 25, 2008REPORT FROM THE ENS 2008 – Deep brain stimulation is an evolving surgical technique for managing patients with advanced PD.